Total Payments
$173,854
2024 Payments
$23,039
Companies
62
Transactions
722
Medicare Patients
779
Medicare Billing
$90,008
Payment Breakdown by Category
Consulting$100,915 (58.0%)
Other$40,024 (23.0%)
Travel$16,272 (9.4%)
Food & Beverage$15,533 (8.9%)
Education$1,110 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $100,915 | 24 | 58.0% |
| Honoraria | $21,945 | 6 | 12.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,019 | 17 | 10.4% |
| Travel and Lodging | $16,272 | 37 | 9.4% |
| Food and Beverage | $15,533 | 634 | 8.9% |
| Education | $1,110 | 3 | 0.6% |
| Debt forgiveness | $60.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Grifols USA, LLC | $88,243 | 75 | $0 (2024) |
| CSL Behring | $26,333 | 71 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $10,133 | 20 | $0 (2024) |
| UCB, Inc. | $9,687 | 39 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $8,626 | 8 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $7,402 | 64 | $0 (2024) |
| PFIZER INC. | $6,553 | 15 | $0 (2024) |
| Akcea Therapeutics, Inc. | $4,374 | 11 | $0 (2020) |
| Shire North American Group Inc | $3,273 | 9 | $0 (2019) |
| Octapharma USA, Inc. | $1,033 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,039 | 92 | Grifols USA, LLC ($13,616) |
| 2023 | $22,460 | 108 | Takeda Pharmaceuticals U.S.A., Inc. ($7,680) |
| 2022 | $27,784 | 69 | Grifols USA, LLC ($17,612) |
| 2021 | $21,060 | 61 | Grifols USA, LLC ($16,000) |
| 2020 | $14,292 | 63 | Grifols USA, LLC ($9,201) |
| 2019 | $26,058 | 88 | Grifols USA, LLC ($8,030) |
| 2018 | $19,463 | 92 | CSL Behring ($13,269) |
| 2017 | $19,698 | 149 | Grifols USA, LLC ($11,677) |
All Payment Transactions
722 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Honoraria | Cash or cash equivalent | $6,000.00 | General |
| Category: Immunology and Neurology | ||||||
| 12/10/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | In-kind items and services | $496.04 | General |
| Category: Immunology and Neurology | ||||||
| 12/10/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | In-kind items and services | $422.45 | General |
| Category: Immunology and Neurology | ||||||
| 12/10/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $300.00 | General |
| Category: Immunology and Neurology | ||||||
| 12/10/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | In-kind items and services | $164.87 | General |
| Category: Immunology and Neurology | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Rare Disease | ||||||
| 12/02/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $122.77 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $104.17 | General |
| Category: Rare Disease | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $67.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | TerSera Therapeutics LLC | Quzyttir (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Acute Care | ||||||
| 09/24/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Neurology | ||||||
| 09/20/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: Neurology | ||||||
| 09/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: PAIN | ||||||
| 09/09/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $19.11 | General |
| Category: Critical Care | ||||||
| 09/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Rare Disease | ||||||
| 09/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 8 | 338 | 478 | $120,085 | $36,607 |
| 2020 | 10 | 441 | 614 | $190,439 | $53,401 |
Total Patients
779
Total Services
1,092
Medicare Billing
$90,008
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 182 | $42,952 | $12,190 | 28.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 57 | 75 | $21,900 | $8,294 | 37.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 133 | $20,216 | $7,559 | 37.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $9,750 | $2,137 | 21.9% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 18 | 18 | $7,042 | $1,924 | 27.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 24 | 24 | $5,040 | $1,850 | 36.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $6,750 | $1,346 | 19.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $6,435 | $1,306 | 20.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 144 | 266 | $62,396 | $18,783 | 30.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 55 | 55 | $35,618 | $8,304 | 23.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 134 | $20,272 | $6,025 | 29.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2020 | 15 | 19 | $21,700 | $5,442 | 25.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 42 | 42 | $20,770 | $4,853 | 23.4% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 18 | 18 | $7,682 | $2,571 | 33.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 24 | 25 | $7,296 | $2,316 | 31.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 22 | 29 | $6,027 | $2,223 | 36.9% |
| 95924 | Testing of autonomic (sympathetic) nervous system function, at least 5 minutes of tilt | Office | 2020 | 13 | 14 | $5,188 | $1,667 | 32.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2020 | 11 | 12 | $3,490 | $1,218 | 34.9% |
About Dr. David Saperstein, MD
Dr. David Saperstein, MD is a Neurology healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871585711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Saperstein, MD has received a total of $173,854 in payments from pharmaceutical and medical device companies, with $23,039 received in 2024. These payments were reported across 722 transactions from 62 companies. The most common payment nature is "Consulting Fee" ($100,915).
As a Medicare-enrolled provider, Saperstein has provided services to 779 Medicare beneficiaries, totaling 1,092 services with total Medicare billing of $90,008. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Scottsdale, AZ
- Active Since 08/17/2005
- Last Updated 12/04/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1871585711
Products in Payments
- Gamunex-C (Biological) $88,441
- Hizentra (Biological) $24,453
- HYQVIA (Biological) $10,107
- ONPATTRO (Drug) $7,568
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $6,400
- TEGSEDI (Drug) $4,374
- GAMMAGARD LIQUID (Biological) $3,155
- SOLIRIS (Drug) $3,081
- AMVUTTRA (Drug) $1,030
- PANZYGA (Biological) $1,021
- ZEJULA (Drug) $1,000
- VYVGART (Drug) $722.71
- Quzyttir (Drug) $717.58
- UBRELVY (Drug) $516.14
- ULTOMIRIS (Biological) $493.28
- Aimovig (Biological) $387.87
- QULIPTA (Drug) $338.00
- Soliris (Drug) $236.16
- APTIOM (Drug) $230.26
- Rebif (Biological) $228.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Scottsdale
Dr. Nida Laurin, M.d, M.D
Neurology — Payments: $1.2M
Neurology $1.2M
Dr. Amaal Starling, M.d, M.D
Neurology — Payments: $314,467
Neurology $314,467
Dr. Dean Wingerchuk, M.d, M.D
Neurology — Payments: $314,438
Neurology $314,438
Dr. Virgilio Evidente, M.d, M.D
Neurology — Payments: $280,162
Neurology $280,162
Dr. Cornelia Drees, M.d, M.D
Neurology — Payments: $171,652
Neurology $171,652
Dr. Charles Adler, M.d, M.D
Neurology — Payments: $112,803
Neurology $112,803